Impact on postmenopausal symptoms of adding continuous C-21 versus C-19 progestin to estrogen.

Wolfe, B M

Impact on postmenopausal symptoms of adding continuous C-21 versus C-19 progestin to estrogen. [electronic resource] - Maturitas Oct 1999 - 153-61 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0378-5122

10.1016/s0378-5122(99)00053-5 doi


Adverse Drug Reaction Reporting Systems
Climacteric--drug effects
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Estrogen Replacement Therapy
Female
Humans
Medroxyprogesterone Acetate--administration & dosage
Middle Aged
Norgestrel--administration & dosage
Prospective Studies